These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 33081988)

  • 1. An update into the medicinal chemistry of translocator protein (TSPO) ligands.
    Barresi E; Robello M; Costa B; Da Pozzo E; Baglini E; Salerno S; Da Settimo F; Martini C; Taliani S
    Eur J Med Chem; 2021 Jan; 209():112924. PubMed ID: 33081988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) Ligands.
    Taliani S; Pugliesi I; Da Settimo F
    Curr Top Med Chem; 2011; 11(7):860-86. PubMed ID: 21291396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of 18 kDa mitochondrial translocator protein (TSPO) in programmed cell death, and effects of steroids on TSPO expression.
    Veenman L; Gavish M
    Curr Mol Med; 2012 May; 12(4):398-412. PubMed ID: 22348610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [18 kDa translocator protein--implications in cell's functions].
    Kołodziejczyk A
    Postepy Hig Med Dosw (Online); 2015 Jan; 69():34-50. PubMed ID: 25589712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VDAC activation by the 18 kDa translocator protein (TSPO), implications for apoptosis.
    Veenman L; Shandalov Y; Gavish M
    J Bioenerg Biomembr; 2008 Jun; 40(3):199-205. PubMed ID: 18670869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response.
    Veenman L; Papadopoulos V; Gavish M
    Curr Pharm Des; 2007; 13(23):2385-405. PubMed ID: 17692008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the mitochondrial permeability transition pore by the outer membrane does not involve the peripheral benzodiazepine receptor (Translocator Protein of 18 kDa (TSPO)).
    Šileikytė J; Blachly-Dyson E; Sewell R; Carpi A; Menabò R; Di Lisa F; Ricchelli F; Bernardi P; Forte M
    J Biol Chem; 2014 May; 289(20):13769-81. PubMed ID: 24692541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translocator protein ligands as promising therapeutic tools for anxiety disorders.
    Taliani S; Da Settimo F; Da Pozzo E; Chelli B; Martini C
    Curr Med Chem; 2009; 16(26):3359-80. PubMed ID: 19548867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mitochondrial translocator protein (TSPO): a key multifunctional molecule in the nervous system.
    El Chemali L; Akwa Y; Massaad-Massade L
    Biochem J; 2022 Jul; 479(13):1455-1466. PubMed ID: 35819398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring Translocator Protein (TSPO) Medicinal Chemistry: An Approach for Targeting Radionuclides and Boron Atoms to Mitochondria.
    Giordani A; Menziani MC; Moresco RM; Matarrese M; Paolino M; Saletti M; Giuliani G; Anzini M; Cappelli A
    J Med Chem; 2021 Jul; 64(14):9649-9676. PubMed ID: 34254805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translocator protein (TSPO) in breast cancer.
    Mukherjee S; Das SK
    Curr Mol Med; 2012 May; 12(4):443-57. PubMed ID: 22348612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translocator protein as a promising target for novel anxiolytics.
    Costa B; Da Pozzo E; Martini C
    Curr Top Med Chem; 2012; 12(4):270-85. PubMed ID: 22204481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of TSPO ligands on mitochondrial function in mouse microglia cells.
    Bader S; Wolf L; Milenkovic VM; Gruber M; Nothdurfter C; Rupprecht R; Wetzel CH
    Psychoneuroendocrinology; 2019 Aug; 106():65-76. PubMed ID: 30954920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial translocator protein (TSPO): From physiology to cardioprotection.
    Morin D; Musman J; Pons S; Berdeaux A; Ghaleh B
    Biochem Pharmacol; 2016 Apr; 105():1-13. PubMed ID: 26688086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TSPO ligand residence time influences human glioblastoma multiforme cell death/life balance.
    Costa B; Da Pozzo E; Giacomelli C; Taliani S; Bendinelli S; Barresi E; Da Settimo F; Martini C
    Apoptosis; 2015 Mar; 20(3):383-98. PubMed ID: 25413799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Synthesis and Anxiolytic Activity Evaluation of N-Acyltryptophanyl- Containing Dipeptides, Potential TSPO Ligands.
    Gudasheva TA; Deeva OA; Mokrov GV; Dyabina AS; Yarkova MA; Seredenin SB
    Med Chem; 2019; 15(4):383-399. PubMed ID: 30457052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligands of the mitochondrial 18 kDa translocator protein attenuate apoptosis of human glioblastoma cells exposed to erucylphosphohomocholine.
    Kugler W; Veenman L; Shandalov Y; Leschiner S; Spanier I; Lakomek M; Gavish M
    Cell Oncol; 2008; 30(5):435-50. PubMed ID: 18791274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational studies on translocator protein (TSPO) and its ligands.
    Ortore G; Tuccinardi T; Martinelli A
    Curr Top Med Chem; 2012; 12(4):352-9. PubMed ID: 22204485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TSPO: kaleidoscopic 18-kDa amid biochemical pharmacology, control and targeting of mitochondria.
    Gatliff J; Campanella M
    Biochem J; 2016 Jan; 473(2):107-21. PubMed ID: 26733718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid hormone synthesis in mitochondria.
    Miller WL
    Mol Cell Endocrinol; 2013 Oct; 379(1-2):62-73. PubMed ID: 23628605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.